Skip to main content
. 2016 Jan 8;7(6):6902–6915. doi: 10.18632/oncotarget.6849

Table 1. Prime and DNA substrates.

Name Oligonucleotide sequence Application
Pol β R152C F 5′-gggactttgaaaaaagaattccttgtgaagagatgttacaaatg-3′ Mutagenesis
Pol β R152C R 5′-ttgcatttgtaacatctcttcacaaggaattcttttttcaaagtccc-3′
Pol β -2oli 5′-ct tacacgttgact accgt
5′-ggatccactcttgcctcaaaagacggtagtcaacg tgtaag-3′
Polymerase activity
Pol-β -3oli 5′-ct tacacgttgact accgt ttttgaggcaagagt ggat cc-3
5′-ggatccactcttgcctcaaaagacggtagtcaacgtgtaa g-3′
Polymerase activity & DNA binding assay
Pol β -U 5′-c ttacacgttgac taccttUtttgaggcaagagtgga t cc-3′
5′-ggatc cactc ttgcc tcaaa gaagg tagtcaacgt gtaag-3′
SP-BER assay
Pol β -F 5′-c ttacacgttgac tacctt Ftttgaggcaagagtgga tcc-3′
5′-ggatccactcttgcctcaaagaaggtagtcaacgtgtaag-3′
LP-BER assay